These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26616890)

  • 21. Response to ustekinumab in a patient with both severe psoriasis and hypertrophic cutaneous lupus.
    Winchester D; Duffin KC; Hansen C
    Lupus; 2012 Aug; 21(9):1007-10. PubMed ID: 22438028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lupus erythematosus tumidus: a clinical entity still being defined].
    Rodríguez-Caruncho C; Bielsa I
    Actas Dermosifiliogr; 2011 Nov; 102(9):668-74. PubMed ID: 21798482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphea in a Crohn's disease patient undergoing ustekinumab treatment.
    Makihara-Inukai M; Takeichi T; Ogawa-Momohara M; Muro Y; Akiyama M
    Eur J Dermatol; 2021 Feb; 31(1):96-97. PubMed ID: 33495147
    [No Abstract]   [Full Text] [Related]  

  • 24. Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.
    Čarija A; Ivić I; Marasović-Krstulović D; Puizina-Ivić N
    Rheumatology (Oxford); 2015 Nov; 54(11):2114-6. PubMed ID: 26242857
    [No Abstract]   [Full Text] [Related]  

  • 25. Systemic lupus erythematosus following rituximab treatment for non-Hodgkin lymphoma.
    Soura E; Avgerinou G; Papoutsaki M; Stavropoulos P; Antoniou C
    J Dtsch Dermatol Ges; 2016 Mar; 14(3):298-301. PubMed ID: 26788717
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful ustekinumab treatment in a patient with psoriasis and subacute cutaneous lupus erythematosus.
    Mazgaj M; Picard-Dahan C; Deschamps L; Marinho E; Estève E; Descamps V
    Int J Dermatol; 2020 Apr; 59(4):e118-e120. PubMed ID: 31957866
    [No Abstract]   [Full Text] [Related]  

  • 27. Sertraline associated discoid lupus erythematosus-like eruption.
    Hill VA; Hepburn NC
    J R Army Med Corps; 1998 Jun; 144(2):109-10. PubMed ID: 9695055
    [No Abstract]   [Full Text] [Related]  

  • 28. A Case of Severe Transaminase Elevation Following a Single Ustekinumab Dose with Remission After Drug Withdrawal.
    Lovero R; Losurdo G; Mastromauro M; Castellaneta NM; Mongelli A; Gentile A; Di Leo A; Principi M
    Curr Drug Saf; 2018; 13(3):221-223. PubMed ID: 30027852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of recalcitrant discoid lupus erythematosus with ustekinumab.
    Romero-Maté A; García-Donoso C; Hernández-Núñez A; Martínez-Morán C; Moreno-Torres A; Borbujo-Martínez J
    Dermatol Online J; 2017 Jan; 23(1):. PubMed ID: 28329473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Benign lymphocytic infiltration: its differential diagnosis with localized lupus erythematosus and polymorphic solar eruption].
    García-Pérez A; Morán Gutiérrez C; Martín Pascual A; Parra Ortiz I
    Actas Dermosifiliogr; 1966; 57(3):65-76. PubMed ID: 5959650
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term therapy with ustekinumab for psoriasis in a patient with a history of malignant melanoma.
    Gkalpakiotis S; Arenberger P; Fridman M; Arenbergerova M
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28730674
    [No Abstract]   [Full Text] [Related]  

  • 32. Severe Small-Vessel Vasculitis Temporally Associated With Administration of Ustekinumab.
    MacArthur KM; Merkel PA; Van Voorhees AS; Nguyen J; Rosenbach M
    J Drugs Dermatol; 2016 Mar; 15(3):359-62. PubMed ID: 26954323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Worsening of Psoriatic Arthritis After Ustekinumab Treatment.
    Onsun N; Yalcin B; Sallahoglu K; Rezvani A
    Am J Ther; 2018; 25(3):e381-e382. PubMed ID: 29189317
    [No Abstract]   [Full Text] [Related]  

  • 34. Ustekinumab treatment in a patient with psoriasis and systemic lupus erythematosus.
    Chyuan IT; Tsai TH; Chang TH; Wu CS
    Lupus; 2015 May; 24(6):650-1. PubMed ID: 25413358
    [No Abstract]   [Full Text] [Related]  

  • 35. Current treatment of cutaneous lupus erythematosus.
    Werth V
    Dermatol Online J; 2001 Feb; 7(1):2. PubMed ID: 11328623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Jessner lymphocytic infiltration - rare in childhood.
    Petersen MP; Vestergaard V; Bygum A
    Dermatol Online J; 2017 Oct; 23(10):. PubMed ID: 29469790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversible Posterior Leukoencephalopathy Syndrome (RPLS) in a Psoriasis Patient Treated With Ustekinumab.
    Dickson L; Menter A
    J Drugs Dermatol; 2017 Feb; 16(2):177-179. PubMed ID: 28300862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New developments in American dermatology].
    Hollander A
    Hautarzt; 1974 Feb; 25(2):49-54. PubMed ID: 4276269
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of hidradenitis suppurativa in a patient treated with ustekinumab for her psoriasis: A potential paradoxical reaction?
    Gkini MA; Bewley AP
    Dermatol Ther; 2018 Nov; 31(6):e12742. PubMed ID: 30221819
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug-induced interstitial lung disease (DILD) during treatment with ustekinumab].
    Sorger C; Simon JC; Treudler R
    Hautarzt; 2020 Apr; 71(4):309-312. PubMed ID: 31792580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.